Login
ICON PLC logo

ICON PLC

iconplc.com

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The firm is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. The company offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The firm's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. The company also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Financial Snapshot

Revenue
TTM
$8.330B
Gross Margin
TTM
24.24%
Net Income
TTM
$69.55M
Current Assets
2026 Q2
$3.749B
Current Liabilities
2026 Q2
$3.935B
Current Ratio
2026 Q2
95.27%
Total Assets
2026 Q2
$16.40B
Total Liabilities
2026 Q2
$7.022B
Book Value
2026 Q2
9.378B
Cash
2026 Q2
$928.4M
P/E
TTM
182.9
Free Cash Flow
TTM
$883.8M

Stock Price

Loading...
Market Cap: $12.719 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support